Morphological variability and its impact on survival in sinonasal malignancies: a 13-year analysis
European Archives of Oto-Rhino-Laryngology · 2025
DOI: 10.1007/s00405-024-09079-w ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2025. Verfasst von Kay Volkheimer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Depatment of Pneumology, University Hospital Rostock, 18057, Rostock, Germany. kayvolkheimer@gmx.de. Hauptthemen laut MEDLINE: Paranasal Sinus Neoplasms, Adenocarcinoma, Nose Neoplasms, Melanoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Despites a tripling of recognised occupational sinonasal adenocarcinomas in the past three decades, no comprehensive publications of the epidemiological development and histological distribution of sinonasal malignancies exist in Germany. Therefore, this study aims to analyse population-related data and address gaps in the nationwide cancer registry. METHODOLOGY: The German Center for Cancer Registry Data (ZfKD) provided a dataset covering the period from 2003 to 2015. 8332 cases were extracted, morphologically clustered and underwent descriptive analysis. Incidence and mortality rates were standardised, and overall survival (OS) probability was estimated. RESULTS: Standardised incidence rates increased, averaging 1.8 for men and 1.0 for women per 100,000 inhabitants. Sinonasal cancer manifested mostly in the nasal cavity with a 5-year OS of 63%. In contrast, malignancies in the frontal sinus had a less favourable survival probability (p < 0.001). Morphologically, the tumour entities comprised 55% squamous cell carcinomas, 18% adenocarcinomas, 8% mucosal melanomas, 4% esthesioneuroblastomas and 2% sinonasal undifferentiated carcinomas (SNUC). The highest 5-year OS rate was observed in esthesioneuroblastomas (59%), while SNUC (38%) and mucosal melanoma (29%) had the lowest (p < 0.001). CONCLUSIONS: This study provides a comprehensive epidemiological analysis of sinonasal morphologies based on a unique dataset. Findings reveal a higher incidence and lower survival probability among men. The topographical distribution varies by sex and tumour entity. The mortality rate for patients with sinonasal cancer is moderate to high, particularly for SNUC and mucosal melanoma, with incidences of 8.4% and 2%, respectively. Hence, there is an urgent need for an optimised screening for early-stage malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Depatment of Pneumology, University Hospital Rostock, 18057, Rostock, Germany. kayvolkheimer@gmx.de.
- , Hofholzallee 59, 24109, Kiel, Germany. kayvolkheimer@gmx.de.
- Asklepios Medical School, Hamburg, Germany.
- Asklepios Tumorzentrum Hamburg, Hamburg, Germany.
- Depatment of Radiation Oncology, Asklepios Klinik St. Georg, Hamburg, Germany.
- Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Plastic Surgery, Asklepios Klinik St. Georg, Hamburg, Germany.
Zitieren
APA
Volkheimer, K., Butt, Y., & Meyer, J. E. (2025). Morphological variability and its impact on survival in sinonasal malignancies: a 13-year analysis. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-024-09079-w
Vancouver
Volkheimer K, Butt Y, Meyer JE. Morphological variability and its impact on survival in sinonasal malignancies: a 13-year analysis. European Archives of Oto-Rhino-Laryngology. 2025. doi:10.1007/s00405-024-09079-w
BibTeX
@article{Volkheimer2025,
author = {Volkheimer, Kay and Butt, Yasmin and Meyer, Jens E},
title = {Morphological variability and its impact on survival in sinonasal malignancies: a 13-year analysis},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2025},
doi = {10.1007/s00405-024-09079-w}
}
EUVIMED